| So something they briefly touch on is new research chemicals. What they don't mention is what happened earlier this year. FOSTA has slaughtered many avenues of sourcing research chemicals. It is significantly more difficult to get them from a reliable source then it was this time last year. While this doesn't stop anyone sufficiently determined, it's harder to get a source of say fentanyl or U-47770 to cut with. The US has been cracking down on producers of these in China, and many chinese or US based resellers have either ceased to exist or changed their operation (US seems to be heavily targeting opioids, China seems to be going after ketamine and analogs) . In addition the Darknet Markets have taken a big hit from Operation Bayonet. It's not to say that DNMs or their vendors or customers are gone, just they're finding it harder to regroup. Though there have been a number of high profile busts from the data of Operation Bayonet This applies to more then just opioids though. Other drugs with overdose potential, like stimulants are just harder to get a hold of. Most US domestic sellers seem to focus on benzodiazepine analogs. We'll see how long this lasts though, I doubt that whole scene is truly gone but it might just be in hibernation for a bit. |